Fundraising Fox

Sente

Carlsbad, US · Delaware corporation

Senté develops medical-grade skincare products built around its patented HSA (heparan sulfate analog) repair molecule, designed to reduce redness, even skin tone, and support the skin barrier for all skin types including sensitive skin. The dermatologist-recommended, clinically tested formulas are sold direct to consumers through kits, sets, and a personalized skincare quiz.

Founders & leadership

LC
Laurent CombredetExecutive
WA
Will AterExecutive
MY
Michael YorkNamed on SEC filing

Board

MF
Marios FotiadisBoard director
KX
Kleanthis XanthopoulosBoard director
PS
Philippe SchaisonBoard director
FH
Faheem HasnainBoard director
MG
Mireille GillingsBoard director
MM
Magda MarquetBoard director

Reported raises · per SEC filings

Form D private placements

$18.5M disclosed across 3 rounds · 2014–2018

$8.5MraisedJun 2018 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Faheem HasnainDirector
  • Will AterExecutive Officer
  • Kleanthis XanthopoulosDirector
  • Mireille GillingsDirector
  • Philippe SchaisonDirector
  • Marios FotiadisDirector
  • Laurent CombredetExecutive Officer
  • Magda MarquetDirector
Offering amount
$18.5M
Amount sold
$8.5M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5MraisedJun 2017 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kleanthis XanthopoulosDirector
  • Philippe SchaisonDirector
  • Faheem HasnainDirector
  • Mireille GillingsDirector
  • Laurent CombredetExecutive Officer
  • Magda MarquetDirector
  • Will AterExecutive Officer
  • Marios FotiadisDirector
Offering amount
$5M
Amount sold
$5M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5MraisedJun 2014 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Magda MarquetDirector
  • Michael YorkExecutive Officer, Director
  • Faheem HasnainDirector
  • Kleanthis XanthopoulosDirector
  • Mireille GillingsDirector
  • Marios FotiadisDirector
Offering amount
$5M
Amount sold
$5M
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Sente for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Sente do?
Senté develops medical-grade skincare products built around its patented HSA (heparan sulfate analog) repair molecule, designed to reduce redness, even skin tone, and support the skin barrier for all skin types including sensitive skin. The dermatologist-recommended, clinically tested formulas are sold direct to consumers through kits, sets, and a personalized skincare quiz.
How much funding has Sente raised?
Sente has disclosed $18.5M raised across 3 rounds.
Where is Sente headquartered?
Sente is headquartered in Carlsbad, US.